AXIM Biotechnologies (AXIM) Stock Statistics & Valuation Metrics

AXIM Biotechnologies has a market cap or net worth of $1.80M. The enterprise value is $8.39M.

AXIM Biotechnologies has 301,958,830 shares outstanding. The number of shares has decreased by -2.65% in one year.

AXIM Biotechnologies’s return on equity (ROE) is 0.34 and return on invested capital (ROIC) is 54.46%.

The current PE Ratio of AXIM Biotechnologies is -0.17. AXIM Biotechnologies’s PEG ratio is -0.01.

In the last 12 months, AXIM Biotechnologies had revenue of 70.46K and earned -3.51M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -855.06K and capital expenditures -2.84K, giving a free cash flow of -857.90K billion.

AXIM Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

AXIM Biotechnologies upcoming earnings date is Mar 19, 2018, TBA (Confirmed).

AXIM Biotechnologies as a current ratio of <0.01, with Debt / Equity ratio of -63.73%

In the past 12 months, AXIM Biotechnologies has paid 0.00 in taxes.

AXIM Biotechnologies EV to EBITDA ratio is -2.96, with an EV/FCF ratio of -8.45.

AXIM Biotechnologies has $245.00 in cash and marketable securities with $6.64M in debt, giving a net cash position of $6.64M billion.

Gross margin is -370.64%, with operating margin of -2502.31%, and net profit margin of -4985.19%.

The average price target for AXIM Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―